Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

NCT00005641 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped low study accrual

Conditions

Chronic Myeloproliferative Disorders
Graft Versus Host Disease
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: leucovorin calcium
DRUG: methotrexate
DRUG: methylprednisolone
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: in vitro-treated bone marrow transplantation
RADIATION: radiation therapy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]